Endovascular Treatment Alone vs. Endovascular Treatment Plus Rheocarna for Patients With Chronic Limb-Threatening Ischemia ― Multicenter Comparative Study ―
Among patients with CLTI and SAD2, EVT combined with Rheocarna significantly improved the wound healing rate at 1 year, although there were no significant differences in terms of wound healing time, major amputation rate, and reintervention at 1 year. These findings suggest that patients with CLTI and SAD2 may be suitable candidates for Rheocarna treatment following EVT.
Authors
- Takashi Yanagiuchi (ORCID: https://orcid.org/0000-0001-5179-1277)
- Naoki Yoshioka (ORCID: https://orcid.org/0000-0002-3619-3794)
- Takahiro Tokuda
- Tatsuya Nakama (ORCID: https://orcid.org/0000-0001-9107-6438)
- Akiko Tanaka (ORCID: https://orcid.org/0000-0003-0238-1436)
- Tatsuro Takei (ORCID: https://orcid.org/0000-0001-8733-473X)
- Kenji Ogata (ORCID: https://orcid.org/0009-0004-7268-6491)
- Shunsuke Kojima
Institutions
- Rakuwakai Otowa Hospital (JP)
- Ogaki Municipal Hospital (JP)
- Nagoya Heart Center (JP)
- Saiseikai Yokohama Eastern Hospital (JP)
- Sendai Kousei Hospital (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1253/circrep.cr-25-0257
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00